Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1691
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18134770 | CARBOBICYCLIC NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTION | Non-Final OA | The Chinese University of Hong Kong |
| 18277524 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | Non-Final OA | LG CHEM, LTD. |
| 19177218 | TERTIARY AMIDE DERIVATIVES SUBSTITUTED WITH 4-MEMBERED RING STRUCTURE | Final Rejection | NATIONAL CANCER CENTER |
| 18990537 | BIFUNCTIONAL MOLECULES FOR SELECTIVE MODIFICATION OF TARGET SUBSTRATES | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 17999364 | BIFUNCTIONAL MOLECULES FOR SELECTIVE MODIFICATION OF TARGET SUBSTRATES | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 18253891 | COMPOSITIONS AND METHODS FOR BLOCKING NEUROPILIN RECEPTOR 1 FOR THE TREATMENT OF PAIN AND PREVENTION OF VIRAL ENTRY | Non-Final OA | Arizona Board of Regents on Behalf of the University of Arizona |
| 17908863 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PANCREATIC CANCER | Non-Final OA | Washington University |
| 18021320 | PYRIMIDINYL SULFONAMIDES AS INHIBITORS OF ACK1/TNK2 TYROSINE KINASE | Non-Final OA | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 18002710 | PanK Modulators and Methods Using Same | Non-Final OA | YALE UNIVERSITY |
| 18041262 | N-CYCLYL-SULFONAMIDES USEFUL FOR INHIBITING RAF | Non-Final OA | ALBERT EINSTEIN COLLEGE OF MEDICINE |
| 18030518 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Non-Final OA | VERTEX PHARMACEUTICALS INCORPORATED |
| 18410317 | METHOD OF USING PIROMELATINE FOR TREATING PARASOMNIAS ASSOCIATED WITH LOSS OF REM SLEEP ATONIA | Non-Final OA | NEURIM PHARMACEUTICALS (1991) LTD. |
| 17823793 | TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS | Non-Final OA | Omeros Corporation |
| 18455098 | VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERS | Non-Final OA | ORYZON GENOMICS, S.A. |
| 17318921 | THE USE OF CHOLINE SUPPLEMENTATION AS THERAPY FOR APOE4-RELATED DISORDERS | Non-Final OA | Whitehead Institute for Biomedical Research |
| 18270616 | FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | Non-Final OA | Tabomedex Biosciences, Inc. |
| 18257959 | AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Non-Final OA | GT APEIRON THERAPEUTICS LIMITED |
| 17936089 | METHODS AND COMPOSITIONS FOR TREATING CANCER | Non-Final OA | Engine Biosciences Pte. Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy